CHEMED CORP (CHE) Stock News
NYSE:CHE - New York Stock Exchange, Inc. - US16359R1032 - Common Stock - Currency: USD
CHE Latest News, Press Relases and Analysis
AMED or CHE: Which Is the Better Value Stock Right Now?
AMED vs. CHE: Which Stock Is the Better Value Option?
Mentions: AMED
Chemed (CHE) Up 2.7% Since Last Earnings Report: Can It Continue?
Chemed (CHE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend
Chemed Corporation to Present at the 2025 RBC Global Healthcare Conference
Chemed Corporation to Present at the Bank of America Securities Health Care Conference 2025
OPCH or CHE: Which Is the Better Value Stock Right Now?
OPCH vs. CHE: Which Stock Is the Better Value Option?
Mentions: OPCH
Chemed Corporation (CHE): A Bull Case Theory
We came across a bullish thesis on Chemed Corporation (CHE) on Substack by 310 Value. In this article, we will summarize the bulls’ thesis on CHE. Chemed Corporation (CHE)’s share was trading at $585.46 as of April 23rd. CHE’s trailing and forward P/E were 29.43 and 23.26 respectively, according to Yahoo Finance. Chemed Corporation exemplifies how durable […]
Chemed (CHE) Surpasses Q1 Earnings and Revenue Estimates
Chemed (CHE) delivered earnings and revenue surprises of 0.54% and 1.67%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: ELAN
Chemed Reports First-Quarter 2025 Results
Chemed Corporation (CHE) Shares Retreated by -13% During TimesSquare U.S. FOCUS Growth Strategy’s Holding Period
TimesSquare Capital Management, an equity investment management company, released its “U.S. Focus Growth Strategy” fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here. In the fourth quarter, the strategy returned -1.35% (gross) and -1.56% (net) compared to 8.14% for the Russell Midcap Growth Index. In the fourth quarter, the U.S. small […]
Mentions: COMP
Chemed To Report First-Quarter 2025 Earnings April 23, Related Conference Call To Be Held On April 24
Chemed Corporation to Present at the Oppenheimer 35th Annual Healthcare Conference
Chemed’s (NYSE:CHE) Q4: Beats On Revenue
Healthcare services company Chemed Corporation (NYSE:CHE) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 9.2% year on year to $640 million. Its non-GAAP profit of $6.83 per share was 0.7% above analysts’ consensus estimates.
